Infusion Therapy Devices Market Report 2026

Infusion Therapy Devices Market Overview

• Infusion Therapy Devices market size has reached to $13.33 billion in 2025 • Expected to grow to $21.82 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: Increasing Prevalence Of Chronic Diseases Is Driving The Growth Of The Market • Market Trend: Innovations In Infusion Therapy Devices With Focus On Pressure-Enabled Drug Delivery (PEDD) Technology • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Infusion Therapy Devices Market?

Infusion therapy devices refer to medical devices used to deliver fluids, medications, nutrients, or blood products directly into a patient's bloodstream. Infusion therapy devices are utilized in highly versatile ways, improving patient care by providing accurate, controlled delivery of fluids, medications, and nutrition. The main types of products of infusion therapy devices are intravenous (IV) sets, cannulas, and needleless connectors. Infusion pumps refer to medical devices used to deliver controlled amounts of fluids, medications, or nutrients into a patient's body. The various mobility options, such as portable infusion pumps and stationary pumps are used for various applications such as oncology, diabetes, pain management, and other applications. These are catering to various end users such as hospitals and clinics, ambulatory surgical centers, home care, and other end users.

What Is The Infusion Therapy Devices Market Growth Forecast?

The infusion therapy devices market size is expected to see rapid growth in the next few years. It will grow to $21.82 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to increasing demand for home healthcare services, rising adoption of connected medical devices, expansion of personalized medicine delivery, growing focus on reducing medication errors, increasing investments in smart hospital infrastructure. Major trends in the forecast period include increasing adoption of smart infusion pumps, rising demand for portable and ambulatory infusion devices, growing integration of dose error reduction systems, expansion of home-based infusion therapy, enhanced focus on patient safety and monitoring.

Global Infusion Therapy Devices Market Segmentation

1) By Product: Infusion Pumps, Intravenous (Iv) Sets, Cannulas, Needleless Connectors 2) By Mobility: Portable Infusion Pumps, Stationary Pumps 3) By Application: Oncology, Diabetes, Pain Management, Other Applications 4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Homecare, Other End-Users Subsegments: 1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Ambulatory Infusion Pumps, Insulin Infusion Pumps 2) By Intravenous (IV) Sets: Standard IV Sets, Extension IV Sets, IV Administration Sets with Filters 3) By Cannulas: Peripheral Intravenous (PIV) Cannulas, Central Venous Cannulas, Butterfly Cannulas 4) By Needleless Connectors: Positive Pressure Needleless Connectors, Neutral Pressure Needleless Connectors, Negative Pressure Needleless Connectors

What Is The Driver Of The Infusion Therapy Devices Market?

Increasing prevalence of chronic diseases is expected to propel the growth of the infusion therapy devices market going forward. Chronic diseases refer to long-lasting health conditions that persist for a year or more and require ongoing medical attention or limit activities of daily living. The increasing prevalence of chronic diseases can be due to poor lifestyle choices, sedentary habits, unhealthy diets, and environmental influences, as well as the rise in risk factors such as obesity, smoking, and stress. Infusion therapy devices manage chronic diseases by providing precise, controlled delivery of medications and fluids directly into the bloodstream, ensuring consistent and effective treatment for conditions such as diabetes, autoimmune disorders, and cancer, thereby improving patient outcomes, enhancing convenience, and reducing the need for frequent hospital visits. For instance, in January 2023, according to the National Center for Biotechnology Information (NCBI), a US-based National Library of Medicine, it is projected that by the year 2050, the number of individuals aged 50 years and above who have at least one chronic illness will surge by 99.5%, rising from 71.522 million in 2020 to 142.66 million. Therefore, the increasing prevalence of chronic diseases is driving the growth of the infusion therapy devices industry.

Key Players In The Global Infusion Therapy Devices Market

Major companies operating in the infusion therapy devices market are Roche Holding AG, Fresenius Kabi AG, Medtronic plc, Medline Industries Inc., Baxter International Inc., Terumo Corporation, Mindray Medical International Limited, Nipro Corporation, ICU Medical Inc., Cook Medical, LivaNova PLC, Vygon S.A., AngioDynamics Inc., B. Braun Melsungen AG, Moog Medical Devices Group, Kangaroo, Vantage Medical Technologies, Alaris Medical Systems Inc., Smiths Medical, Teleflex Incorporated

Global Infusion Therapy Devices Market Trends and Insights

Major companies operating in the infusion therapy devices market are focusing on developing innovative solutions such as the pressure-enabled drug delivery (PEDD) technology to enhance the treatment of liver and pancreatic tumors. Pressure-enabled drug delivery (PEDD) refers to a drug delivery technology that uses pressure to enhance the infusion of therapeutic agents into tissues or organs, particularly in areas where conventional methods may face challenges. For instance, in November 2024, TriSalus Life Sciences, a US-based medical technology company, launched the TriNav LV Infusion System and TriGuide Guiding Catheters, expanding its pressure-enabled drug delivery (PEDD) portfolio to optimize therapeutic delivery, enhancing treatment options and potentially improving outcomes for patients. The TriNav LV Infusion System offers unique features such as larger blood vessels (3.5 to 5.0 mm), expanding the use of TriSalus' Pressure-Enabled Drug Delivery (PEDD) technology to a broader patient population. This launch extends PEDD device compatibility from 1.5 mm to 5.0 mm vessels, offering interventional radiologists more treatment options. TriGuide Guiding Catheters feature a larger inner diameter, lubricious lining, and a reverse curve design for easier femoral access and improved procedural efficiency. Early users report a 97% satisfaction rate, highlighting the system’s effectiveness and ease of use in oncology treatments.

What Are Latest Mergers And Acquisitions In The Infusion Therapy Devices Market?

In July 2024, ICU Medical Inc., a US-based company that offers medical technology acquired Smiths Medical Inc. for an undisclosed amount. Through this acquisition, ICU Medical is to enhance its infusion therapy product line and expand its portfolio into newer clinical care markets with a more robust offering in infusion systems and related products. Smiths Medical Inc. is a US-based manufacturer of medical devices that involve infusion therapy devices.

Regional Outlook

North America was the largest region in the infusion therapy devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Infusion Therapy Devices Market?

The infusion therapy devices market consists of sales of products including pumps, catheters, sets, ports, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.